XIV. The rationale for combining targeted and biological anti‐lymphoma drugs
Year: 2013
Type: article
Source: Hematological Oncology
DOI: 10.1002/hon.2072
Author: Anas Younes
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1551273588
